The Vector™ PTA Balloon Dilatation Catheter is recommended for Percutaneous Transluminal Angioplasty (PTA) of the femoral, iliac, popliteal, and renal arteries and for the treatment of obstructive lesions of native or synthetic arterio-venous dialysis fistulae.

The Vector" Catheter is not indicated for use in the coronary arteries or for placement of or post dilatation of stents.

Device Description

The Vector™ PTA Balloon Dilatation Catheter is a high pressure, non-compliant balloon catheter. It is a coaxial dual lumen over-the-wire balloon dilatation catheter. The central lumen accommodates guide wires up to the 0.035 inches in diameter while the outer lumen is the inflation lumen for the balloon.

The balloon is a high pressure composite balloon with radio-opaque marker bands to help visualize the balloon placement within the vasculature during both placement and inflation. The balloon's rated burst pressure is 30 atm.

AI/ML Overview

The provided document is a 510(k) summary for a medical device called the Vector™ PTA Balloon Dilatation Catheter (K143652). It outlines the device's technical characteristics, intended use, and a summary of performance testing to establish substantial equivalence to a predicate device.

Here's an analysis to extract the requested information:

1. A table of acceptance criteria and the reported device performance

Acceptance Criteria / Performance Specification	Reported Device Performance
Rated Burst Pressure	Met specifications
Balloon Compliance	Met specifications
Balloon Diameter Sizing	Met specifications
Inflation/Deflation Times	Met specifications
Repeat Inflation	Met specifications
Removal/Refold & Reuse	Met specifications
Flexibility / Kink	Met specifications
Crossing Profile	Met specifications
Balloon Protector Removal	Met specifications
Guidewire/Introducer Compatibility	Met specifications
Tensile Strength	Met specifications
Visibility under Fluoro-imaging	Met specifications
Torque Strength	Met specifications
Catheter Leak	Met specifications
Sterilization (SAL 10-6)	Achieved via Ethylene Oxide
Biocompatibility (ISO 10993-1)	Met requirements

2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

The document does not explicitly state the specific sample sizes used for each individual test. It mentions "All devices met the performance specifications" implying that a sufficient number of devices were tested for each performance characteristic. The data provenance is not specified, but the testing would typically be internal bench testing conducted by the manufacturer. It is not a clinical study, so concepts like country of origin or retrospective/prospective don't apply in the same way.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

This document describes bench testing of a device's physical and functional properties, not a diagnostic or AI device that relies on expert interpretation to establish "ground truth." Therefore, this question is not applicable. The "ground truth" for these tests are the engineering specifications and established test methods.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

This question is not applicable as the document describes bench testing of a physical device, not an assessment requiring expert adjudication of clinical outcomes or diagnostic interpretations.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

This question is not applicable. This is a 510(k) submission for a physical medical device (balloon catheter), not an AI/CAD diagnostic device.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

This question is not applicable. This is a physical medical device, not an algorithm.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

For the performance tests described (Rated Burst Pressure, Balloon Compliance, etc.), the "ground truth" is defined by the engineering specifications, industry standards, and established test methodologies. For example, the rated burst pressure is a design specification that the device must meet or exceed. There is no expert consensus, pathology, or outcomes data involved in establishing "ground truth" for these types of bench tests.

8. The sample size for the training set

This question is not applicable. This is a physical medical device, not a machine learning model, so there is no "training set."

9. How the ground truth for the training set was established

This question is not applicable. As there is no training set, there is no ground truth for it.

Summary

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image is a black and white logo for the U.S. Department of Health and Human Services. The logo features a stylized image of an eagle with three human profiles incorporated into its design. The profiles are facing to the right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

February 26, 2015

Vector Corporation LLC c/o Ms. Laurie Lewandowski Honkanen Consulting, Inc. 738 Saddle Wood Drive Eagan, MN 55123

Re: K143652

Trade/Device Name: Vector PTA Balloon Dilatation Catheter Regulation Number: 21 CFR 870.1250 Regulation Name: Percutaneous Catheter Regulatory Class: Class II Product Code: LIT Dated: January 30, 2015 Received: February 2, 2015

Dear Ms. Lewandowski:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical

{1}------------------------------------------------

device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Kenneth J. Cavanaugh -S

for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K143652

Device Name

Vector™ PTA Balloon Dilatation Catheter

Indications for Use (Describe)

The Vector™ PTA Balloon Dilatation Catheter is recommended for Percutaneous Transluminal Angioplasty (PTA) of the femoral, iliac, popliteal, and renal arteries and for the teatment of obstructive or synthetic arterio-venous dialysis fistulae.

The Vector Catheter is not indicated for use in the coronary arteries or for placement of or post dilation of stents.

Type of Use (Select one or both, as applicable)

X Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.

FOR FDA USE ONLY

Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)

l Health (CDRH) (Signature)

{3}------------------------------------------------

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{4}------------------------------------------------

510(k) Summary

Vector Corporation

Primary Contact Person

Laurie Lewandowski, Consultant Honkanen Consulting, Inc. 738 Saddle Wood Drive Eagan, MN 55123 Phone: 612-770-4038 Email: lalew207@gmail.com

Sponsor's Contact

Jay Sturm Vector Corporation LLC 1270 Ave of Americas. Suite 302 New York, NY 10020 Phone: 646-833-3700 Email: jsturm(a)volcanocap.com

Device Name

Trade Name: Vector™ Common Name: Percutaneous Catheter Classification Name: Percutaneous Catheter Classification: II Product Code: LIT Regulation Number: 21 CFR 870.1250

Predicate Device

The device is substantially equivalent to the r4 Vascular, Inc. Vector4™ PTA Balloon Dilatation Catheter (K131329).

Indications for Use/Intended Use

The Vector" Catheter is not indicated for use in the coronary arteries or for placement of or post dilatation of stents.

{5}------------------------------------------------

Device Description

Technological Characteristics

The Vector™ PTA Balloon Dilatation Catheter was cleared under K131329. The fundamental scientific technology and technological characteristics for the Vector™ PTA Balloon Catheter remain the same as Vector4™ PTA Balloon Dilatation Catheter.

Vector™ is a coaxial dual lumen over-the-wire balloon dilatation catheter. The central lumen accommodates guide wires up to 0.035 inches in diameter while the outer lumen is the inflation lumen for the balloon. The catheter includes an atraumatic tip to ease advancement of the catheter to and through the stenosis.

The balloon is a high pressure, Parylene coated, composite balloon with marker bands located at the proximal and distal end of the balloon working length and at the distal tip to help visualize placement within the lesion or stenosis. The balloon's rated burst pressure is 30 atm.

The catheter is supplied sterile and non-pyrogenic. Different balloon sizes (5 mm to 10 mm) and catheter lengths (50 to 135 cm) are available. The proximal end of the catheter contains a hub with two female luer locks.

The device is compatible with 6-7F introducers. The introducer compatibility for each device size is listed on the device label. The materials used in the construction are biocompatible and not made with natural rubber latex.

The modifications to the Vector™ PTA Balloon Dilatation Catheter are as follows.

1. Removal of radiopaque coating, BaSO4 tip doping and addition of marker bands
1. Angled the balloon fibers and modified the fiber denier
1. Updates to the IFU for company name, product name, use of contrast
1. Increased flow for reduced inflation / deflation times
1. Increased product robustness for balloon bonds and reduction in introducer withdrawal force
1. The 6 Fr balloon protector ID was increased slightly.

There are no changes in the balloon catheter dimensions or significant changes in weight with these modifications.

{6}------------------------------------------------

Performance Data

Based on the risk analysis of the modified device, and testing was conducted on the modified Vector™ PTA Balloon Dilatation Catheter. The testing performed on the modified devices was:

Rated Burst Pressure, Balloon Compliance, Balloon Diameter Sizing, Inflation/deflation times. Repeat Inflation. Removal/Refold & Reuse. Flexibility / Kink, Crossing Profile, Balloon Protector Removal, Guide wire/Introducer Compatibility, Tensile Strength, Visibility under Fluoro-imaging, Torque Strength and Catheter Leak.

All devices met the performance specifications.

The device is sterilized by ethylene oxide to an SAL 10-6 level and the device is biocompatible meeting the requirements of ISO 10993-1.

The bench testing demonstrated that the device meets specifications indicating that the device is as safe and effective as the predicate device.

Substantial Equivalence

The modified Vector" PTA Balloon Catheter is substantially equivalent to the Vector4™ PTA catheter (K131329). They have the identical intended use, and treat the same target population. Both devices are intended to treat peripheral arteries. The manner in accessing and treating lesions in all these arteries is identical. The devices are similar in design with changes as described.

Conclusion

The modified Vector" PTA Balloon Catheters and the predicate Vector4™ PTA Balloon Catheters have identical intended use and similar technological characteristics and are therefore substantially equivalent. Bench testing of the Vector™ PTA Balloon Dilatation Catheters demonstrated that all product specifications were met. These tests demonstrate that the Vector" PTA Balloon Dilatation Catheters are as safe and effective as the predicate device.

Regulation Number and Section

§ 870.1250 Percutaneous catheter.

(a)
Identification. A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.(b)
Classification. Class II (performance standards).